Regional brain function in hallucinations: A study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls

Comprehensive Psychiatry

Volumn 30, Issue 1, 1989, Pages 99-108

  Musalek, M ^a,b   Podreka, I ^a,b   Walter, H ^a,b   Suess, E ^a,b   Passweg, V ^a,b   Nutzinger, D ^a,b   Strobl, R ^a,b   Lesch, O M ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Department of Neurology School of Medicine University of Vienna ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HALLUCINATION; HUMAN;

ADULT; AUDITORY PERCEPTION; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; FEMALE; HALLUCINATIONS; HUMAN; MALE; MIDDLE AGE; ORGANOMETALLIC COMPOUNDS; OXIMES; PILOT PROJECTS; REGIONAL BLOOD FLOW; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED; TOUCH;

EID: 0024494073     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-440X(89)90123-5     Document Type: Article

References (69)

1. Hallucinations: Theoretical and clinical overview
2. Organic delusions: Phenomenology, anatomical correlations, and review
3. Peduncular hallucinations caused by brainstem compression
4. Die Stellung des Zwischenhirns in psychozerebralen Apparat
5. The brain's record of auditory and visual experience
6. Hallucinations and delusions following a right temporoparieto-occipital infarction
7. Study of cerebral function with positron computed tomography
8. Cerebral glucography with postitron tomography
9. Clinical correlates of decreased antero-posterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients
10. Positron emission tomography in schizophrenic patients with and without neuroleptic medication
11. Abnormal distribution of cerebral activity in chronic schizophrenia
12. Regional cerebral blood flow in schizophrenia
13. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography
14. Application of 〈18F〉2-deoxy-2-fluro-d-glucose and positron emission tomography in the study of psychiatric conditions
15. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
16. Regional cerebral blood flow in schizophrenia
17. Positron emission tomographic image measurement in schizophrenia and affective disorders
18. Antero-posterior gradients in cerebral glucose use in schizophrenia and affective disorders
19. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with 〈18F〉2-deoxyglucose in affective disorders
20. Hypofrontality in schizophrenia as assessed by PET
21. A study of cerebral blood flow and metabolism in epileptic psychosis using positron emission tomography and oxygen
22. Regional brain function in schizophrenia. (I. A positron emission tomography study)
23. Blood flow and oxidative metabolism of the brain in patients with schizophrenia
24. 15D positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients
25. Regional brain function on schizophrenia. (II. Repeated evaluation with positron emission tomography)
26. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression
27. Approaches to the assessment of schizophrenia in Europe
28. Schizophrenie u. Wahnkrankheiten
29. Detection of rCBF changes in partial complex seizures or hallucinations by isopropyl (I-123)p-iodoamphetamine (IMP) SPECT
30. IMP-SPECT bei Temporallappenepilepsie und Halluzinose
31. Delusions of parasitosis
32. Delusional parasitosis and physical disease
33. Manifestations neurologiques et psychiatriques des parasitoses
34. Delusions of parasitosis
35. Delusional parasitosis: A form of monosymptomatic hypochondriacal psychosis
36. Die chronische taktile Halluzinose
37. Der praesenile Dermatozoenwahn
38. Psychopathological concepts of dysphoria
39. Dysphoric states in the course of manic-depressive illness
40. The regulation of the blood supply of the brain
41. Distribution of cerebral blood flow in the dominant hemisphere during motor ideation and motor performance
42. Hemispheric specialization in normal man studied by bilateral measurements of the regional cerebral blood flow
43. Visual cortex activation recorded by dynamic emission computed tomography of inhalated xenon-133
44. Positron emission tomography and computed tomography assessment of the aging human brain
45. Cerebral glucose utilization as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years
46. Human brain glucose utilization and cognitive function in relation to age
47. Cerebral glucose metabolism as a function of age in man: Influence of the rate constants in the age. Flurodeoxyglucose method
48. Relation of measured brain glucose utilization and cerebral atrophy in man
49. Normal distribution of regional cerebral blood flow measured by dynamic single-photon emission tomography
50. Effects of human aging on patterns of local cerebral glucose utilization determined by the 〈18 F〉 fluoro-deoxyglucose method
51. Effects of neurotropic drugs on glucose metabolism in rat brain in vivo
52. Distribution of effects of haloperidol on energy metabolism in the rat brain
53. Effect of triperidol on carbohydrate and aminoacid metabolism in rat brain-cortex
54. Regional changes of cerebral blood flow during haloperidol therapy in patients with paranoid symptoms
55. PET studies of glucose metabolism in patients with schizophrenia
56. Regional brain glucose metabolism in chronic schizophrenia
57. Glucose metabolism in patients with schizophrenia: Emission computed tomography measurements with 11-C-glucose
58. Prominence of basal ganglia metabolic activity in schizophrenia
59. The third dimension